Authors: Viola Guardigni, MD, and Monty Montano, PhD

Although there is substantial enthusiasm for the development of HIV vaccines^1,2 a remaining challenge is the treatment of people who are infected and under the care
of a clinician. The introduction of effective combination antiretroviral therapy (cART) dramatically increased life expectancy in people aging with HIV (PAWH).³ In developed countries, a growing percentage of PAWH are soon to be older than 50 years, due to a longer life expectancy and to acquiring HIV infection later in life. (...

On April 27, 2017, the HU CFAR and the Ragon Institute hosted the Physician-Scientist Symposium "The role of the physician-scientist in the evolving landscape of biomedical research."  Drs. Lenette Lu, Amy Barczak and Doug Kwon hosted the meeting locally with the goals of:

• highlighting the excellent work by physician-scientists from around the country
• exploring the variety of ways in which clinical training influences research
• developing ideas of how to more completely support the careers of physician-...

2018 National CFAR Meeting

HU CFAR Internal Competition-Early Stage Investigator (ESI) Call for Abstracts

Emory University is pleased to welcome Early Stage Investigators (ESIs) as participants in the Science Symposium on Thursday, November 8 and at a Mentoring Workshop on Friday, November 9 at the 2018 National CFAR Meeting...

Promising findings lead to initiation of a clinical efficacy trial in southern Africa

BOSTON - More than three decades after the identification of the human immunodeficiency virus (HIV), scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year. 

...

The George Washington University School of Medicine and Health Sciences (SMHS) invites applications and nominations for the position of chair of the Department of Microbiology, Immunology, & Tropical Medicine (MITM).

Apply here: https://www.gwu.jobs/postings/51785

The HPTN is seeking applicants for a 50% academic ID doctor to serve as a clinical trials physician for some of the major studies.  This is a great opportunity for emerging investigators interested in HIV prevention research.

...

Looking for a NIH Program Official in Your Research Area?

For years researchers have used the Matchmaker feature in NIH RePORTER to identify NIH-funded projects similar to their supplied abstracts, research bios, or other scientific text. Matchmaker was recently enhanced to make it just as easy to identify NIH program officials whose portfolios include projects in your research area.

After entering your scientific text (up to 15,000 characters), Matchmaker will analyze the key terms and concepts to identify up to 500 similar projects. Those projects will continue...

The second iteration of the FOA Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21 Clinical Trial Optional)” was just published.

Here it is. ...

This is an opportunity that may be of interest to early-stage HIV investigators who would like an opportunity for short-term training. This proposal is not tied to the CFAR grant and is a standalone submission to CDRF but funded by OAR.

• Early-stage investigators from Brazil, China, India, Russia, South Africa, and the United States of America
• Each up to $25,000 United States Dollars (USD) for up to 3 months of short-term training support...

The Department of Medicine (DOM) at MGH has an initiative to support faculty applying for R01 grants.

They are offering the opportunity for pre-submission review of drafts of R01 grants. Dozens of NIH-funded DOM research faculty have volunteered to make themselves available to read and provide feedback. Although optional, they hope that many investigators will take advantage of this pre-review process.

Details on how to participate in pre-submission review of R01 grants can be found...